Significant Transactions - Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | | | |
Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 |
Cash flows from operating activities | | | | | | | | | | | | | | | |
Net income | | $ 167 | $ 152 | $ 12 | $ 130 | $ 16 | $ 61 | $ 47 | $ 28 | $ 461 | $ 152 | $ 270 | | | |
Reconciling adjustments: | | | | | | | | | | | | | | | |
Provision for finance receivable losses | | 277 | $ 254 | $ 259 | 253 | 229 | $ 242 | $ 233 | 243 | 1,043 | 947 | 929 | | | |
Depreciation and amortization | | | | | | | | | | 279 | 317 | 510 | | | |
Deferred income tax benefit | | | | | | | | | | 21 | 43 | (105) | | | |
Net gain on liquidation of United Kingdom Subsidiary | | | | | | | | | | 0 | 0 | (4) | | | |
Net gain on sales of personal and real estate loans and related trust assets | [1] | | | | | | | | | (2) | 0 | (18) | | | |
Net loss on repurchases and repayments of debt | | | | | | | | | | 9 | 29 | 17 | | | |
Share-based compensation expense, net of forfeitures | | | | | | | | | | 10 | 5 | 8 | | | |
Net gain on sale of SpringCastle interests | | | | | | | | | | 0 | 0 | (167) | | | |
Other | | | | | | | | | | 15 | (5) | (9) | | | |
Cash flows due to changes in: | | | | | | | | | | | | | | | |
Other assets and other liabilities | | | | | | | | | | | 175 | (189) | | | |
Insurance claims and policyholder liabilities | | | | | | | | | | | (22) | (64) | | | |
Taxes receivable and payable | | | | | | | | | | | 43 | (38) | | | |
Accrued interest and finance charges | | | | | | | | | | | (37) | 15 | | | |
Other, net | | | | | | | | | | | 0 | 3 | | | |
Net cash provided by operating activities | | | | | | | | | | 1,967 | 1,647 | 1,158 | | | |
Cash flows from investing activities | | | | | | | | | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | | | | | | | (2,372) | (2,267) | (1,155) | | | |
Proceeds on sales of finance receivables held for sale originated as held for investment | | | | | | | | | | 100 | 0 | 930 | | | |
Proceeds from sale of SpringCastle interests, net of restricted cash released | | | | | | | | | | 0 | 0 | 26 | | | |
Cash advances on intercompany notes receivables | | | | | | | | | | (34) | (355) | (297) | | | |
Proceeds from repayments of principal and assignment of intercompany notes receivable | | | | | | | | | | 187 | 249 | 401 | | | |
Cash received from CitiFinancial Credit Company | | | | | | | | | | | | 23 | | | |
Available-for-sale securities purchased | | | | | | | | | | (680) | (671) | (746) | | | |
Trading and other securities purchased | | | | | | | | | | | | (17) | | | |
Available-for-sale securities called, sold, and matured | | | | | | | | | | 563 | 739 | 837 | | | |
Trading and other securities called, sold, and matured | | | | | | | | | | 36 | 18 | 63 | | | |
Proceeds from sale of real estate owned | | | | | | | | | | | 4 | 8 | | | |
Other, net | | | | | | | | | | | 3 | (10) | | | |
Net cash provided by (used for) investing activities | | | | | | | | | | (2,238) | (2,280) | 63 | | | |
Cash flows from financing activities | | | | | | | | | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | | | | | | | 5,525 | 5,427 | 6,660 | | | |
Repayments of long-term debt | | | | | | | | | | (5,471) | (4,447) | (8,320) | | | |
Proceeds from intercompany note payable | | | | | | | | | | | 0 | 0 | | | |
Payments on intercompany note payable | | | | | | | | | | | 0 | | | | |
Cash dividend of SFMC | | | | | | | | | | 0 | (10) | 0 | | | |
Distributions to joint venture partners | | | | | | | | | | 0 | 0 | (18) | | | |
Payments on intercompany note payable | | | | | | | | | | (99) | 0 | 0 | | | |
Withholding tax on vested RSUs and PRSUs | | | | | | | | | | (2) | (2) | (1) | | | |
Capital contributions from parent | | | | | | | | | | 0 | 0 | 10 | | | |
Net cash provided by (used for) financing activities | | | | | | | | | | (23) | 968 | (1,669) | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | | | | | | (294) | 335 | (448) | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | | 1,456 | | | | 1,121 | 1,456 | 1,121 | 1,569 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | 1,162 | | | | 1,456 | | | | 1,162 | 1,456 | 1,121 | | | |
Supplemental cash flow information | | | | | | | | | | | | | | | |
Cash and cash equivalents | | | | | | | | | | | | | $ 663 | $ 958 | $ 553 |
Restricted cash and restricted cash equivalents | | | | | | | | | | | | | 499 | 498 | 568 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | $ 1,162 | | | 1,456 | 1,456 | | | 1,121 | 1,456 | 1,121 | 1,569 | $ 1,162 | 1,456 | 1,121 |
Interest paid | | | | | | | | | | (753) | (746) | (765) | | | |
Income taxes received (paid) | | | | | | | | | | (150) | (154) | (269) | | | |
Supplemental non-cash activities | | | | | | | | | | | | | | | |
Transfer of net finance receivables held for investment to finance receivables held for sale (prior to deducting allowance for finance receivable losses) | | | | | | | | | | 111 | 0 | 1,945 | | | |
Increase in finance receivables held for investment financed with intercompany payable | | | | | | | | | | 0 | 0 | 89 | | | |
Transfer of finance receivables to real estate owned | | | | | | | | | | 7 | 9 | 8 | | | |
Net unsettled investment security purchases | | | | | | | | | | | 1 | 1 | | | |
Non-cash dividend of SFMC | | | | | | | | | | 0 | (28) | 0 | | | |
Independence | | | | | | | | | | | | | | | |
Cash flows from operating activities | | | | | | | | | | | | | | | |
Net income | | | | | | | | | | | 58 | 37 | | | |
Reconciling adjustments: | | | | | | | | | | | | | | | |
Provision for finance receivable losses | | | | | | | | | | | 623 | 600 | | | |
Depreciation and amortization | | | | | | | | | | | 174 | 366 | | | |
Deferred income tax benefit | | | | | | | | | | | 125 | (22) | | | |
Net gain on liquidation of United Kingdom Subsidiary | | | | | | | | | | | | 0 | | | |
Net gain on sales of personal and real estate loans and related trust assets | | | | | | | | | | | | 0 | | | |
Net loss on repurchases and repayments of debt | | | | | | | | | | | 1 | 0 | | | |
Share-based compensation expense, net of forfeitures | | | | | | | | | | | 5 | 7 | | | |
Net gain on sale of SpringCastle interests | | | | | | | | | | | | 0 | | | |
Other | | | | | | | | | | | (6) | (15) | | | |
Cash flows due to changes in: | | | | | | | | | | | | | | | |
Other assets and other liabilities | | | | | | | | | | | 68 | (152) | | | |
Insurance claims and policyholder liabilities | | | | | | | | | | | 70 | (45) | | | |
Taxes receivable and payable | | | | | | | | | | | 30 | (94) | | | |
Accrued interest and finance charges | | | | | | | | | | | 54 | 1 | | | |
Other, net | | | | | | | | | | | 3 | 0 | | | |
Net cash provided by operating activities | | | | | | | | | | | 1,205 | 683 | | | |
Cash flows from investing activities | | | | | | | | | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | | | | | | | | (1,484) | (598) | | | |
Proceeds on sales of finance receivables held for sale originated as held for investment | | | | | | | | | | | | 0 | | | |
Proceeds from sale of SpringCastle interests, net of restricted cash released | | | | | | | | | | | | 0 | | | |
Cash advances on intercompany notes receivables | | | | | | | | | | | 0 | (670) | | | |
Proceeds from repayments of principal and assignment of intercompany notes receivable | | | | | | | | | | | 0 | 670 | | | |
Cash received from CitiFinancial Credit Company | | | | | | | | | | | | 23 | | | |
Available-for-sale securities purchased | | | | | | | | | | | (431) | (399) | | | |
Trading and other securities purchased | | | | | | | | | | | | (7) | | | |
Available-for-sale securities called, sold, and matured | | | | | | | | | | | 438 | 457 | | | |
Trading and other securities called, sold, and matured | | | | | | | | | | | 17 | 43 | | | |
Proceeds from sale of real estate owned | | | | | | | | | | | 0 | 0 | | | |
Other, net | | | | | | | | | | | (9) | (36) | | | |
Net cash provided by (used for) investing activities | | | | | | | | | | | (1,469) | (517) | | | |
Cash flows from financing activities | | | | | | | | | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | | | | | | | | 1,971 | 2,806 | | | |
Repayments of long-term debt | | | | | | | | | | | (1,898) | (3,394) | | | |
Proceeds from intercompany note payable | | | | | | | | | | | 1,486 | 1,415 | | | |
Payments on intercompany note payable | | | | | | | | | | | (905) | | | | |
Cash dividend of SFMC | | | | | | | | | | | 0 | | | | |
Distributions to joint venture partners | | | | | | | | | | | | 0 | | | |
Payments on intercompany note payable | | | | | | | | | | | | (1,292) | | | |
Withholding tax on vested RSUs and PRSUs | | | | | | | | | | | (1) | 0 | | | |
Capital contributions from parent | | | | | | | | | | | | 0 | | | |
Net cash provided by (used for) financing activities | | | | | | | | | | | 653 | (465) | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | | | | | | | 389 | (299) | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | | 1,043 | | | | 654 | 1,043 | 654 | 953 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | | | | | 1,043 | | | | | 1,043 | 654 | | | |
Supplemental cash flow information | | | | | | | | | | | | | | | |
Cash and cash equivalents | | | | | | | | | | | | | | 714 | 313 |
Restricted cash and restricted cash equivalents | | | | | | | | | | | | | | 329 | 341 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | 1,043 | 1,043 | | | 654 | 1,043 | 654 | 953 | | 1,043 | 654 |
Interest paid | | | | | | | | | | | (310) | (314) | | | |
Income taxes received (paid) | | | | | | | | | | | (83) | (129) | | | |
Supplemental non-cash activities | | | | | | | | | | | | | | | |
Transfer of net finance receivables held for investment to finance receivables held for sale (prior to deducting allowance for finance receivable losses) | | | | | | | | | | | | 0 | | | |
Increase in finance receivables held for investment financed with intercompany payable | | | | | | | | | | | | 0 | | | |
Transfer of finance receivables to real estate owned | | | | | | | | | | | 0 | 0 | | | |
Net unsettled investment security purchases | | | | | | | | | | | 1 | 1 | | | |
Non-cash dividend of SFMC | | | | | | | | | | | 0 | | | | |
As Reported SFC | | | | | | | | | | | | | | | |
Cash flows from operating activities | | | | | | | | | | | | | | | |
Net income | | | | | | | | | | | 94 | 233 | | | |
Reconciling adjustments: | | | | | | | | | | | | | | | |
Provision for finance receivable losses | | | | | | | | | | | 324 | 329 | | | |
Depreciation and amortization | | | | | | | | | | | 143 | 144 | | | |
Deferred income tax benefit | | | | | | | | | | | (82) | (83) | | | |
Net gain on liquidation of United Kingdom Subsidiary | | | | | | | | | | | | (4) | | | |
Net gain on sales of personal and real estate loans and related trust assets | | | | | | | | | | | | (18) | | | |
Net loss on repurchases and repayments of debt | | | | | | | | | | | 28 | 17 | | | |
Share-based compensation expense, net of forfeitures | | | | | | | | | | | 0 | 1 | | | |
Net gain on sale of SpringCastle interests | | | | | | | | | | | | (167) | | | |
Other | | | | | | | | | | | 1 | 6 | | | |
Cash flows due to changes in: | | | | | | | | | | | | | | | |
Other assets and other liabilities | | | | | | | | | | | 107 | (37) | | | |
Insurance claims and policyholder liabilities | | | | | | | | | | | (92) | (19) | | | |
Taxes receivable and payable | | | | | | | | | | | 13 | 56 | | | |
Accrued interest and finance charges | | | | | | | | | | | (95) | 14 | | | |
Other, net | | | | | | | | | | | (3) | 3 | | | |
Net cash provided by operating activities | | | | | | | | | | | 438 | 475 | | | |
Cash flows from investing activities | | | | | | | | | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | | | | | | | | (783) | (557) | | | |
Proceeds on sales of finance receivables held for sale originated as held for investment | | | | | | | | | | | | 930 | | | |
Proceeds from sale of SpringCastle interests, net of restricted cash released | | | | | | | | | | | | 26 | | | |
Cash advances on intercompany notes receivables | | | | | | | | | | | (1,837) | (1,042) | | | |
Proceeds from repayments of principal and assignment of intercompany notes receivable | | | | | | | | | | | 1,154 | 1,023 | | | |
Cash received from CitiFinancial Credit Company | | | | | | | | | | | | 0 | | | |
Available-for-sale securities purchased | | | | | | | | | | | (245) | (353) | | | |
Trading and other securities purchased | | | | | | | | | | | | (10) | | | |
Available-for-sale securities called, sold, and matured | | | | | | | | | | | 301 | 380 | | | |
Trading and other securities called, sold, and matured | | | | | | | | | | | 1 | 20 | | | |
Proceeds from sale of real estate owned | | | | | | | | | | | 4 | 8 | | | |
Other, net | | | | | | | | | | | 12 | 26 | | | |
Net cash provided by (used for) investing activities | | | | | | | | | | | (1,393) | 451 | | | |
Cash flows from financing activities | | | | | | | | | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | | | | | | | | 3,456 | 3,854 | | | |
Repayments of long-term debt | | | | | | | | | | | (2,544) | (4,920) | | | |
Proceeds from intercompany note payable | | | | | | | | | | | 0 | 670 | | | |
Payments on intercompany note payable | | | | | | | | | | | 0 | | | | |
Cash dividend of SFMC | | | | | | | | | | | (10) | | | | |
Distributions to joint venture partners | | | | | | | | | | | | (18) | | | |
Payments on intercompany note payable | | | | | | | | | | | | (670) | | | |
Withholding tax on vested RSUs and PRSUs | | | | | | | | | | | (1) | (1) | | | |
Capital contributions from parent | | | | | | | | | | | | 10 | | | |
Net cash provided by (used for) financing activities | | | | | | | | | | | 901 | (1,075) | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | | | | | | | (54) | (149) | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | | 413 | | | | 467 | 413 | 467 | 616 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | | | | | 413 | | | | | 413 | 467 | | | |
Supplemental cash flow information | | | | | | | | | | | | | | | |
Cash and cash equivalents | | | | | | | | | | | | | | 244 | 240 |
Restricted cash and restricted cash equivalents | | | | | | | | | | | | | | 169 | 227 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | 413 | 413 | | | 467 | 413 | 467 | 616 | | 413 | 467 |
Interest paid | | | | | | | | | | | (436) | (451) | | | |
Income taxes received (paid) | | | | | | | | | | | (71) | (140) | | | |
Supplemental non-cash activities | | | | | | | | | | | | | | | |
Transfer of net finance receivables held for investment to finance receivables held for sale (prior to deducting allowance for finance receivable losses) | | | | | | | | | | | | 1,945 | | | |
Increase in finance receivables held for investment financed with intercompany payable | | | | | | | | | | | | 89 | | | |
Transfer of finance receivables to real estate owned | | | | | | | | | | | 9 | 8 | | | |
Net unsettled investment security purchases | | | | | | | | | | | 0 | 0 | | | |
Non-cash dividend of SFMC | | | | | | | | | | | (28) | | | | |
Adjustments | | | | | | | | | | | | | | | |
Cash flows from operating activities | | | | | | | | | | | | | | | |
Net income | | | | | | | | | | | 0 | 0 | | | |
Reconciling adjustments: | | | | | | | | | | | | | | | |
Provision for finance receivable losses | | | | | | | | | | | 0 | 0 | | | |
Depreciation and amortization | | | | | | | | | | | 0 | 0 | | | |
Deferred income tax benefit | | | | | | | | | | | 0 | 0 | | | |
Net gain on liquidation of United Kingdom Subsidiary | | | | | | | | | | | | 0 | | | |
Net gain on sales of personal and real estate loans and related trust assets | | | | | | | | | | | | 0 | | | |
Net loss on repurchases and repayments of debt | | | | | | | | | | | 0 | 0 | | | |
Share-based compensation expense, net of forfeitures | | | | | | | | | | | 0 | 0 | | | |
Net gain on sale of SpringCastle interests | | | | | | | | | | | | 0 | | | |
Other | | | | | | | | | | | 0 | 0 | | | |
Cash flows due to changes in: | | | | | | | | | | | | | | | |
Other assets and other liabilities | | | | | | | | | | | 0 | 0 | | | |
Insurance claims and policyholder liabilities | | | | | | | | | | | 0 | 0 | | | |
Taxes receivable and payable | | | | | | | | | | | 0 | 0 | | | |
Accrued interest and finance charges | | | | | | | | | | | 4 | 0 | | | |
Other, net | | | | | | | | | | | 0 | 0 | | | |
Net cash provided by operating activities | | | | | | | | | | | 4 | 0 | | | |
Cash flows from investing activities | | | | | | | | | | | | | | | |
Net principal originations of finance receivables held for investment and held for sale | | | | | | | | | | | 0 | 0 | | | |
Proceeds on sales of finance receivables held for sale originated as held for investment | | | | | | | | | | | | 0 | | | |
Proceeds from sale of SpringCastle interests, net of restricted cash released | | | | | | | | | | | | 0 | | | |
Cash advances on intercompany notes receivables | | | | | | | | | | | 1,482 | 1,415 | | | |
Proceeds from repayments of principal and assignment of intercompany notes receivable | | | | | | | | | | | (905) | (1,292) | | | |
Cash received from CitiFinancial Credit Company | | | | | | | | | | | | 0 | | | |
Available-for-sale securities purchased | | | | | | | | | | | 5 | 6 | | | |
Trading and other securities purchased | | | | | | | | | | | | 0 | | | |
Available-for-sale securities called, sold, and matured | | | | | | | | | | | 0 | 0 | | | |
Trading and other securities called, sold, and matured | | | | | | | | | | | 0 | 0 | | | |
Proceeds from sale of real estate owned | | | | | | | | | | | 0 | 0 | | | |
Other, net | | | | | | | | | | | 0 | 0 | | | |
Net cash provided by (used for) investing activities | | | | | | | | | | | 582 | 129 | | | |
Cash flows from financing activities | | | | | | | | | | | | | | | |
Proceeds from issuance of long-term debt, net of commissions | | | | | | | | | | | 0 | 0 | | | |
Repayments of long-term debt | | | | | | | | | | | (5) | (6) | | | |
Proceeds from intercompany note payable | | | | | | | | | | | (1,486) | (2,085) | | | |
Payments on intercompany note payable | | | | | | | | | | | 905 | | | | |
Cash dividend of SFMC | | | | | | | | | | | 0 | | | | |
Distributions to joint venture partners | | | | | | | | | | | | 0 | | | |
Payments on intercompany note payable | | | | | | | | | | | | 1,962 | | | |
Withholding tax on vested RSUs and PRSUs | | | | | | | | | | | 0 | 0 | | | |
Capital contributions from parent | | | | | | | | | | | | 0 | | | |
Net cash provided by (used for) financing activities | | | | | | | | | | | (586) | (129) | | | |
Net change in cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | | | | | | | 0 | 0 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period | | | | | 0 | | | | 0 | 0 | 0 | 0 | | | |
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period | | | | | | 0 | | | | | 0 | 0 | | | |
Supplemental cash flow information | | | | | | | | | | | | | | | |
Cash and cash equivalents | | | | | | | | | | | | | | 0 | 0 |
Restricted cash and restricted cash equivalents | | | | | | | | | | | | | | 0 | 0 |
Total cash and cash equivalents and restricted cash and restricted cash equivalents | | | | | $ 0 | $ 0 | | | $ 0 | $ 0 | 0 | 0 | | $ 0 | $ 0 |
Interest paid | | | | | | | | | | | 0 | 0 | | | |
Income taxes received (paid) | | | | | | | | | | | 0 | 0 | | | |
Supplemental non-cash activities | | | | | | | | | | | | | | | |
Transfer of net finance receivables held for investment to finance receivables held for sale (prior to deducting allowance for finance receivable losses) | | | | | | | | | | | | 0 | | | |
Increase in finance receivables held for investment financed with intercompany payable | | | | | | | | | | | | 0 | | | |
Transfer of finance receivables to real estate owned | | | | | | | | | | | 0 | 0 | | | |
Net unsettled investment security purchases | | | | | | | | | | | 0 | $ 0 | | | |
Non-cash dividend of SFMC | | | | | | | | | | | $ 0 | | | | |
| |
[1] | In 2018, the gain on sale of real estate loans has been combined with the resulting impairment on finance receivables held for sale remaining after the December 2018 Real Estate Loan Sale. See Note 2 of the Notes to the Consolidated Financial Statements included in this report for more information regarding the sale. | |